Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Cardiovascular Disease Physician in Hauppauge, NY
NPI: 1346264553Primary Practice Location
SUNY/STONY BROOK UNIVERSITY HOSPITAL
240 Meeting House Ln, Southampton, NY
Primary Employer
Stony Brook Internists
stonybrookmedicine.edu
HQ Phone
Get M.D. Hal's Phone Numberphone_androidMobile
Get M.D. Hal's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
1997 - 2027
MA State Medical License
1992 - 1999
American Board of Internal Medicine
Advanced Heart Failure and Transplant Cardiology
Mass General Brigham/Massachusetts General Hospital
Fellowship • Cardiovascular Disease
1992 - 1997
Yale-New Haven Medical Center
Residency • Internal Medicine
1990 - 1992
Chicago Medical School at Rosalind Franklin University of Medicine and Science
Medical School
Until 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 109 | 219 |
| 2 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 108 | 180 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 103 | 106 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 57 | 92 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 56 | 71 |
Authors: Skopicki, H A, Abraham, S A, Weissman, N J, Mukerjee, A K, Alpert, N M, Fischman, A J, Picard, M H, Gewirtz, H
Journal: Circulation
High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.
Lead Sponsor: Abbott Medical Devices
Intervention / Treatment: DRUG: Warfarin, DEVICE: HeartMate II (HMII), DRUG: acetylsalicylic acid (ASA) therapy
Lead Sponsor: Duke University
Collaborators: Duke Clinical Research Institute
Intervention / Treatment: OTHER: Digital Engagement, OTHER: Direct Engagement
Lead Sponsor: Boehringer Ingelheim
Collaborators: Eli Lilly and Company
Intervention / Treatment: DRUG: Empagliflozin, DRUG: Placebo to Empagliflozin
